Wave Life Sciences Ltd.’s recent filing unveils that its Chief Financial Officer Moran Kyle unloaded Company’s shares for reported $96421.0 on Apr 03 ’24. In the deal valued at $6.17 per share,15,630 shares were sold. As a result of this transaction, Moran Kyle now holds 33,921 shares worth roughly $0.2 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares, generating $5,000,000 in total proceeds. Upon buying the shares at $5.00, the Director now owns 19,202,009 shares.
Before that, GSK plc bought 3,300,000 shares. Wave Life Sciences Ltd. shares valued at $16,500,000 were divested by the 10% Owner at a price of $5.00 per share. As a result of the transaction, GSK plc now holds 13,983,761 shares, worth roughly $80.41 million.
Leerink Partners upgraded its Wave Life Sciences Ltd. [WVE] rating to an Outperform from a a Market perform in a research note published on December 19, 2023; the price target was increased to $12 from $5. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Jefferies also remained covering WVE and has decreased its forecast on May 24, 2023 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of WVE
On Monday, Wave Life Sciences Ltd. [NASDAQ:WVE] saw its stock fall -6.35% to $5.75. Over the last five days, the stock has gained 18.56%. Wave Life Sciences Ltd. shares have risen nearly 13.86% since the year began. Nevertheless, the stocks have risen 57.53% over the past one year. While a 52-week high of $7.67 was reached on 03/07/24, a 52-week low of $3.15 was recorded on 02/14/24. SMA at 50 days reached $5.67, while 200 days put it at $5.10. A total of 0.91 million shares were traded, compared to the trading of 1.24 million shares in the previous session.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 5.57, which if violated will result in even more drops to 5.40. On the upside, there is a resistance level at 6.06. A further resistance level may holdings at 6.38. The Relative Strength Index (RSI) on the 14-day chart is 55.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.20%. Stochastics %K at 79.74% indicates the stock is a holding.
The most recent change occurred on October 23, 2020 when RBC Capital Mkts began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $13 price target.
